Micropulse laser with or without light therapy for chronic CSC
Part of Eyes & vision clinical trials.
This trial compares two treatments for chronic central serous chorioretinopathy (CSC), a condition that causes fluid buildup under the retina. It tests whether adding a light therapy (photodynamic therapy) to micropulse laser treatment helps improve vision more than laser alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have been diagnosed with chronic central serous chorioretinopathy (CSC) for more than 6 months. This is a condition where fluid builds up under the retina, causing blurry or distorted vision.
- You are receiving either a single micropulse laser treatment or a combination of micropulse laser and a drug-free light therapy (photodynamic therapy). You have not had any other laser or eye surgery in the past 6 months.
- You must have follow-up visits at 1 month and at least 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This study measures blood flow in the eye in people with acute or chronic central serous chorioretinopathy (CSC). It uses eye scans and special imaging to better understand what’s happening and whether it may differ between short-term and long-term disease.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
This trial tests a low-energy “subthreshold” laser to treat long-lasting fluid under the retina from central serous chorioretinopathy (CSCR). It may help dry up the fluid and improve vision, compared with a sham (placebo) treatment.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This study is testing whether mindfulness-based stress reduction can help people with central serous chorioretinopathy (CSCR), a condition causing fluid buildup under the retina. If you have active CSCR that started recently, you might be eligible.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.